Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 7 studies | 27% ± 8% | |
adipocyte | 6 studies | 22% ± 6% | |
glutamatergic neuron | 4 studies | 35% ± 16% | |
pericyte | 4 studies | 21% ± 5% | |
neuron | 3 studies | 18% ± 2% | |
epithelial cell | 3 studies | 41% ± 21% | |
fibroblast | 3 studies | 27% ± 8% | |
GABAergic neuron | 3 studies | 32% ± 9% | |
astrocyte | 3 studies | 23% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 28% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 2654.80 | 244 / 245 | 100% | 16.54 | 500 / 502 |
skin | 100% | 7244.57 | 1800 / 1809 | 99% | 37.02 | 468 / 472 |
thymus | 100% | 2533.44 | 651 / 653 | 99% | 15.79 | 597 / 605 |
breast | 100% | 3086.46 | 458 / 459 | 98% | 12.89 | 1100 / 1118 |
esophagus | 100% | 3552.30 | 1439 / 1445 | 98% | 13.22 | 180 / 183 |
lung | 99% | 2277.93 | 572 / 578 | 98% | 11.54 | 1134 / 1155 |
adrenal gland | 100% | 1905.04 | 258 / 258 | 97% | 9.59 | 223 / 230 |
ovary | 100% | 4020.28 | 180 / 180 | 97% | 10.42 | 415 / 430 |
brain | 96% | 1748.24 | 2531 / 2642 | 100% | 19.86 | 705 / 705 |
bladder | 100% | 2195.38 | 21 / 21 | 95% | 10.41 | 481 / 504 |
kidney | 98% | 1428.10 | 87 / 89 | 97% | 12.27 | 876 / 901 |
uterus | 100% | 3117.58 | 170 / 170 | 94% | 11.77 | 431 / 459 |
intestine | 96% | 1946.65 | 931 / 966 | 96% | 9.23 | 504 / 527 |
pancreas | 78% | 781.19 | 257 / 328 | 97% | 11.06 | 173 / 178 |
stomach | 79% | 1338.39 | 282 / 359 | 96% | 9.88 | 274 / 286 |
liver | 64% | 634.68 | 144 / 226 | 60% | 3.73 | 244 / 406 |
blood vessel | 100% | 3064.78 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 35.26 | 80 / 80 |
spleen | 100% | 2227.56 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 3974.87 | 1202 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 12.67 | 44 / 45 |
muscle | 98% | 2638.72 | 785 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 11.94 | 28 / 29 |
heart | 76% | 937.96 | 656 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 38% | 660.94 | 356 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0005829 | Cellular component | cytosol |
GO_0046872 | Molecular function | metal ion binding |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | LONRF1 |
Protein name | LON peptidase N-terminal domain and ring finger 1 LON peptidase N-terminal domain and RING finger protein 1 (RING finger protein 191) |
Synonyms | RNF191 |
Description | |
Accessions | E9PRX6 A0A0C4DGE8 ENST00000534446.1 Q17RB8 H7C5V9 ENST00000398246.8 [Q17RB8-1] E9PQH4 ENST00000524526.2 ENST00000526680.5 ENST00000533751.5 ENST00000525024.5 |